In conclusion, our findings support the view that the specific S1P3 isoform transduces the pro‐inflammatory action of 2‐AG in endometriotic epithelial cells and establishes the rationale for the exploitation of S1P3 targeting as an innovative nonhormonal approach to counteract endometriosis. This evidence concerns the gene S1PR3 and endometriosis.